Strategic Provider of End-to-End Automation Solutions
Strategic Provider of End-to-End Automation Solutions
Focused on Large Attractive End Markets
ATS
TM
Life Sciences
•
•
Medical devices
Pharmaceuticals
Radiopharmaceuticals
Chemicals
F2023 Revenue
$1,210Mn
.
Transportation
Energy
EV / Hybrid
Automotive
⚫ Nuclear
Clean energy
Aerospace
F2023 Revenue
$578Mn
F2023 Revenue
$113Mn
Food & Beverage
• Produce Processing
Sorting & Inspection
Beverage Processing &
Filling
Consumer Products
Warehouse Automation
Personal Care
Cosmetics
F2023 Revenue
$371Mn
F2023 Revenue
$305Mn
Backlog (1)
Backlog(1)
Backlog(1)
Backlog(1)
Backlog(1)
$761Mn
$939Mn
$82Mn
$215Mn
$156Mn
(1) Order Backlog is a supplementary financial measure. Please see "Non-IFRS and Other Financial Measures" and "Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures; as of March 31, 2023
6View entire presentation